Bicara Therapeutics Inc. (BCAX)
Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 20260 patents granted to the name below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Bicara Therapeutics Inc.’s names, not what it holds today.
5 published
| Published | Application | Title | Field | Owner as printed |
|---|---|---|---|---|
| Nov 28, 2024 | 2024/0392031 | CAIX TARGETING IL-12 FUSION PROTEINS AND METHODS OF USE THEREOF | Pharmaceuticals | BICARA THERAPEUTICS INC. |
| Oct 17, 2024 | 2024/0343813 | COMBINATION THERAPY AND RELATED METHODS | Pharmaceuticals | BICARA THERAPEUTICS INC. |
| Jul 11, 2024 | 2024/0228620 | MULTISPECIFIC PROTEINS AND RELATED METHODS | Biotechnology | BICARA THERAPEUTICS INC. |
| Mar 14, 2024 | 2024/0084018 | PHARMACEUTICAL FORMULATIONS FOR FUSION PROTEINS | Pharmaceuticals | BICARA THERAPEUTICS INC. |
| Mar 14, 2024 | 2024/0082394 | COMBINATION THERAPY FOR THE TREATMENT OF CANCER | Pharmaceuticals | BICARA THERAPEUTICS INC. |
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.